Table 1.

case characteristics and tasks.

Patient	Age	Apectrum	Aetails	Task
1	55	Pre-biopsy	Suspicious DRE, PSA 8 ng/ml, PI-RADS 2 lesion	Next diagnostic step
2	65	Screening	Suspicious DRE, PSA 1 ng/ml	Next diagnostic step
3	44	Screening	Positive family history for prostate cancer	Next diagnostic step
4	45	Screening	Afro-American, PSA 2 ng/ml, DRE not suspicious	Next step
5	81	Screening	Severe comorbidities, non-suspicious DRE, PSA 9 ng/ml, asymptomatic for prostate cancer	Next step
6	41	Screening	Positive family history for prostate cancer, known BRCA2 somatic mutation	Next step
7	64	Pre-treatment, intermediate risk	ISUP III in 6/12 biopsies, cT2a, PSA 12 ng/ml, cN0, cM0	Treatment options
8	65	Pre-treatment, high risk	ISUP III in 8/12 biopsies, cT2b, PSA 22 ng/ml, cN0, cM0	Treatment options
9	75	Pre-treatment, high risk	ISUP III in 8/12 biopsies, cT2c, PSA 70 ng/ml, cN0 cM0	Treatment options
10	68	Pre-treatment, low risk	ISUP I in 1/12 biopsies, cT1c, PSA 3.2 ng/ml, Afro-American	Treatment options